Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benefit of Self-sampling for HPV DNA in a General Practitioner's Office to Improve Participation in Cervical Screening - The ASTRA Study.

NCT06253169 is registered in ClinicalTrials.gov with Patient Organization Veronica as lead sponsor.

NCT NCT06253169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06253169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benefit of Self-sampling for HPV DNA in a General Practitioner's Office to Improve Participation in Cervical Screening - The ASTRA Study.
Lead sponsor
Patient Organization Veronica
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2024
Completion date
June 30, 2025
Enrollment
2,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, hpv infection, precancerous lesion